My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 46

    1.

    Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes.

    Shi Y, Sun H, Bao J, Zhou P, Zhang J, Li L, Bu H.

    Am J Pathol. 2011 Sep;179(3):1138-47. Epub 2011 Jul 16.

    PMID:
    21763259
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.

    Ditisheim S, Giostra E, Burkhard PR, Goossens N, Mentha G, Hadengue A, Spahr L.

    BMC Gastroenterol. 2011 Dec 8;11:134.

    PMID:
    22151412
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    3.

    Non-invasive markers for hepatic fibrosis.

    Baranova A, Lal P, Birerdinc A, Younossi ZM.

    BMC Gastroenterol. 2011 Aug 17;11:91. Review.

    PMID:
    21849046
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    4.

    Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis.

    Artinyan A, Marshall CL, Balentine CJ, Albo D, Orcutt ST, Awad SS, Berger DH, Anaya DA.

    Cancer. 2011 Dec 13. doi: 10.1002/cncr.26682. [Epub ahead of print]

    PMID:
    22170573
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Pathophysiology and current management of pruritus in liver disease.

    Kremer AE, Oude Elferink RP, Beuers U.

    Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):89-97. Review.

    PMID:
    21809485
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Liver fibrogenesis and genetic factors.

    Boursier J, Louvet A.

    Clin Res Hepatol Gastroenterol. 2011 Jun;35 Suppl 1:S3-9.

    PMID:
    21742298
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Liver fibrogenesis and metabolic factors.

    Anty R, Lemoine M.

    Clin Res Hepatol Gastroenterol. 2011 Jun;35 Suppl 1:S10-20.

    PMID:
    21742296
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.

    Stallhofer J, Denk GU, Glas J, Laubender RP, Göke B, Rust C, Brand S, Pusl T.

    Digestion. 2011;84(1):29-35. Epub 2011 Feb 8.

    PMID:
    21304239
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Chelation therapy for secondary iron overload: is the primary effect less iron or less liver fibrosis?

    Adams PC.

    Gastroenterology. 2011 Oct;141(4):1142-3. Epub 2011 Aug 24. No abstract available.

    PMID:
    21871454
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.

    Lyoumi S, Abitbol M, Rainteau D, Karim Z, Bernex F, Oustric V, Millot S, Lettéron P, Heming N, Guillmot L, Montagutelli X, Berdeaux G, Gouya L, Poupon R, Deybach JC, Beaumont C, Puy H.

    Gastroenterology. 2011 Oct;141(4):1509-19, 1519.e1-3. Epub 2011 Jul 14.

    PMID:
    21762662
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation.

    Desai MS, Zainuer S, Kennedy C, Kearney D, Goss J, Karpen SJ.

    Gastroenterology. 2011 Oct;141(4):1264-72, 1272.e1-4. Epub 2011 Jul 14.

    PMID:
    21762660
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

    Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.

    Gastroenterology. 2011 Oct;141(4):1212-9. Epub 2011 Jul 14.

    PMID:
    21762659
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.

    Deugnier Y, Turlin B, Ropert M, Cappellini MD, Porter JB, Giannone V, Zhang Y, Griffel L, Brissot P.

    Gastroenterology. 2011 Oct;141(4):1202-11, 1211.e1-3. Epub 2011 Jul 7. Erratum in: Gastroenterology. 2012 Jan;142(1):186.

    PMID:
    21741344
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.

    Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC.

    Gastroenterology. 2011 Oct;141(4):1220-30, 1230.e1-3. Epub 2011 Jul 2.

    PMID:
    21726511
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.

    Van Rooyen DM, Larter CZ, Haigh WG, Yeh MM, Ioannou G, Kuver R, Lee SP, Teoh NC, Farrell GC.

    Gastroenterology. 2011 Oct;141(4):1393-403, 1403.e1-5. Epub 2011 Jun 23.

    PMID:
    21703998
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.

    Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.

    Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. Epub 2011 Jun 22.

    PMID:
    21703214
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.

    Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM; HALT-C Trial Group.

    Gastroenterology. 2011 Sep;141(3):900-908.e1-2. Epub 2011 Jun 12.

    PMID:
    21699796
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.

    Trepo E, Guyot E, Ganne-Carrie N, Degre D, Gustot T, Franchimont D, Sutton A, Nahon P, Moreno C.

    Hepatology. 2012 Apr;55(4):1307-8. doi: 10.1002/hep.25518. No abstract available.

    PMID:
    22162034
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

    Rinella ME.

    Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634. No abstract available.

    PMID:
    21956705
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Drug therapy: telaprevir.

    Leise MD, Kim WR, Canterbury KM, Poterucha JJ.

    Hepatology. 2011 Oct;54(4):1463-9. doi: 10.1002/hep.24660. Review. No abstract available.

    PMID:
    21898509
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk